Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients
Odile Spreux‐Varoquaux(Centre Hospitalier de Versailles), Vincent Meininger(Générale de Santé), Pierre Pradat(Sorbonne Université), Abdellatif Marouan(Centre Hospitalier de Versailles), Lucette Lacomblez(Sorbonne Université), François Salachas(Sorbonne Université), Nadine Le Forestier(Sorbonne Université), Gilbert Bensimon(Pitié-Salpêtrière Hospital), Michel Dib(Hôtel-Dieu de Paris)
Cited by 278
Related Papers
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
|The Lancet|1996|1.3k